HPV11 E7 Antibodies

Santa Cruz Biotechnology features a diverse variety of HPV11 E7 monoclonal antibodies for research in understanding HPV11 E7 protein's role in cellular processes. HPV11 E7 monoclonal antibodies are suitable for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). HPV11 E7 protein functions as a key oncoprotein in the transformation of host cells, contributing to the development of cervical and other anogenital cancers. By interfering with the host's cell cycle regulation, HPV11 E7 promotes uncontrolled cell proliferation, making it an important target for cancer research and therapeutic interventions. Understanding HPV11 E7 mechanisms provides valuable insights into viral pathogenesis and potential strategies for prevention and treatment. Research utilizing HPV11 E7 monoclonal antibodies has revealed significant aspects of viral oncogenesis and cellular transformation processes. Investigating HPV11 E7 interactions with cellular proteins helps elucidate the molecular pathways involved in cancer development. Current studies focusing on HPV11 E7 continue to uncover new aspects of virus-host interactions. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of HPV-related diseases and potential therapeutic approaches.